Neos Therapeutics (NEOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | |
| Sales | 758 | 1,044 |
| Cost of Goods | 3,391 | 2,534 |
| Gross Profit | -2,633 | -1,490 |
| Operating Expenses | 16,230 | 16,132 |
| Operating Income | -18,472 | -17,088 |
| Interest Expense | 2,520 | 2,115 |
| Other Income | 143 | 603 |
| Pre-tax Income | -20,849 | -18,600 |
| Net Income Continuous | -20,849 | -18,600 |
| Net Income Discontinuous | N/A | -437 |
| Net Income | $-20,849 | $-19,037 |
| EPS Basic Total Ops | -27.56 | -28.45 |
| EPS Basic Continuous Ops | -23.80 | -27.90 |
| EPS Basic Discontinuous Ops | N/A | -0.55 |
| EPS Diluted Total Ops | -27.56 | -28.45 |
| EPS Diluted Continuous Ops | -23.80 | -27.90 |
| EPS Diluted Discontinuous Ops | N/A | -0.55 |
| EPS Diluted Before Non-Recurring Items | -27.56 | N/A |
| EBITDA(a) | $-15,577 | $-14,775 |